Nawah Scientific, an Egypt-born deeptech and life sciences platform, has secured $23 million in Series A funding. The round will fuel regional and global expansion. It will also strengthen research infrastructure across the Middle East and Africa. With this raise, Nawah moves closer to its goal of building world class scientific capacity from the region to the world.
A Strong Series A Backed by Strategic Investors
Life Ventures Holding led the funding round. Several deeptech and life sciences investors joined the raise. These included Den Venture, Empire M, AfricInvest, and Elsewedy. Angel investors and banking partners also participated.
The round used a blended structure. It combined equity, debt, and grant funding. This structure gives Nawah financial flexibility while supporting long term research investment.
Key outcomes of the round include:
- Capital for regional and global expansion
- Funding for advanced laboratory infrastructure
- Support for long term research and innovation
Scaling a Research First Business Model
Dr. Omar Shokry Saqr, Founder and CEO, stated that the funding supports Nawah’s next growth phase. The company plans to expand its geographic footprint while upgrading research capabilities.
Nawah will:
- Build a new global research hub in Rwanda
- Double lab capacity in Egypt and Saudi Arabia
- Expand total operational space beyond 20,000 square meters
The company focuses on sustainable growth. It prioritizes scientific depth over short term scale.
Ten Years of Investment in Science
Nawah has invested nearly $7 million in research and development over the past decade. The company supports innovation across healthcare, pharmaceuticals, and agriculture.
Its core business units include:
- Life Sciences, focused on oncology, stem cells, and nanotechnology
- Pharma Services, supporting drug development and manufacturing
- Food and Agriculture, specializing in soil and crop analysis
- Reference Materials, supporting quality and compliance needs
Each unit addresses real market gaps across emerging economies.
Expanding a Global Footprint
Nawah currently operates in Cairo, Riyadh, the UAE, and Poland. The company plans to enter Rwanda and South Africa next. These moves aim to bring advanced research services closer to underserved markets.
The Series A signing took place during Nawah’s tenth anniversary event. Egypt’s Ministry of Higher Education and Scientific Research hosted the ceremony. Senior officials, investors, and research partners attended.
GAFI CEO Hossam Heiba praised Nawah as a national success model. He highlighted its role in linking scientific research with economic growth.
Global Recognition and Regulatory Leadership
Nawah has received support from Egypt Ventures. The government backed entity promotes entrepreneurship and innovation. The company also earned a spot on the YASR30 list by Yale Africa Startup Review, backed by the Jack Ma Foundation.
A major milestone sets Nawah apart. It became the first African research center accredited by the US FDA. This approval strengthens its global credibility and regulatory standing.
With new capital and clear expansion plans, Nawah Scientific stands ready to lead deeptech innovation from Egypt to the world.